Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
From www.bloodjournal.org by guest on June 18, 2017. For personal use only. 1644 (page 1662) used friendlier starting material than plasma, factor VIII/vWF concentrates, and employed conventional chromatography on heparin, ion exchange, and size exclusion columns. From the products of these independent purification methods, both groups obtained the same protein sequence. The vWF protease is a 150-kd singlechain glycoprotein that requires divalent metal ions. Exploring the human genomic database, Fujikawa and colleagues found a match between their N-terminal protein sequence and an EST cluster from chromosome 9q34. This composite cDNA sequence encodes a metalloprotease belonging to the ADAMTS subfamily, although the expected thrombospondin domain is not part of this partial sequence. ADAMTS proteases typically contain both zinc and calcium ions, and the congruence between the known properties of the vWF protease and ADAMTS proteases provides additional compelling evidence that the vWF protease has been identified. To what use might this initial information be applied? It is likely that polyclonal and monoclonal antibodies can be prepared against the deduced protein sequence, making quantitation of plasma protease antigen and a rapid diagnostic test for TTP no more than a clinical ELISA away. But a significant fraction of patients with microangiopathy have normal levels of this protease, and new tools based on this new pro- tease should facilitate the dissection of these potentially distinct entities that converge on a common TTP-like phenotype. Ultimately, completion of the cDNA sequence will lead to production of recombinant protein, which could enable specific therapy for the rare patient with congenital TTP and possibly for patients with low-titer autoantibodies. Eventually we should be able to prove or refute the UL-vWF multimer theory of TTP, thereby moving us one step closer to a cure. —Kenneth Kaushansky University of Washington Endothelial cells: they only look all alike In this issue, Morigi and colleagues (page 1828) provide experimental evidence that delineates a pathogenetic mechanism for the postdiarrheal hemolytic uremic syndrome of children. Their findings suggest that the localization of platelet thrombi in the arteriolar circulation and capillaries, as typically seen in the disease, is the consequence of a distinct response of microvascular endothelial cells to verotoxin produced by E coli. These results illustrate 2 concepts that may prove of general significance in our understanding of the causes that trigger arterial thrombosis. First, the paper provides a welldocumented example of the heterogeneity of endothelial cells, based on the variable BLOOD, 15 SEPTEMBER 2001 䡠 VOLUME 98, NUMBER 6 expression of specific molecules that determine a distinct response to stimuli. Evidence is accumulating that the genetic programming of endothelial cells not only differs in arteries and veins, as well as in larger and smaller vessels, but also defines unique environments in the vascular bed of organs that may explain the preferential localization of disease processes. Thus the same event in different vessels may lead to variable outcomes. Second, the proposed explanation for the effect of verotoxin is a further demonstration of the link between infections and arterial thrombosis. Epidemiologic and experimental studies have called attention to the fact that bacteria and bacterial products may be involved in precipitating acute occlusive incidents on the background of chronic degenerative alterations, such as seen in atherosclerosis. Morigi and colleagues’ results add support to the hypothesis that infections or other stimuli may induce specific changes in gene expression that, for example, could alter the make up of proadhesive molecules in the extracellular matrix and enhance the likelihood of platelet deposition on a ruptured plaque. We have known for some time that endothelial cells are not just a passive barrier to flowing blood. Now we are learning with increasing clarity that their dynamic responses may have a remarkable variety of regional flavors. —Zaverio M. Ruggeri Scripps Research Institute From www.bloodjournal.org by guest on June 18, 2017. For personal use only. 2001 98: 1644 doi:10.1182/blood.V98.6.1644 Endothelial cells: they only look all alike Zaverio M. Ruggeri Updated information and services can be found at: http://www.bloodjournal.org/content/98/6/1644.full.html Articles on similar topics can be found in the following Blood collections Information about reproducing this article in parts or in its entirety may be found online at: http://www.bloodjournal.org/site/misc/rights.xhtml#repub_requests Information about ordering reprints may be found online at: http://www.bloodjournal.org/site/misc/rights.xhtml#reprints Information about subscriptions and ASH membership may be found online at: http://www.bloodjournal.org/site/subscriptions/index.xhtml Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly by the American Society of Hematology, 2021 L St, NW, Suite 900, Washington DC 20036. Copyright 2011 by The American Society of Hematology; all rights reserved.